(1<i>R</i>,3<i>S</i>)-3-(1<i>H</i>-Benzo[<i>d</i>]imidazol-2-yl)-1,2,2-trimethylcyclopentane-1-carboxylic acid as a new anti-diabetic active pharmaceutical ingredient
Acta crystallographica. Section E, Crystallographic communications